The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps. (Q37912062)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818672 AND SRC:MED&resulttype=core&format=json

9 February 2020

review article

1 reference

title

The human papillomavirus (HPV) vaccine and cervical cancer: uptake and next steps (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818672 AND SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

cervix uterine cancer

1 reference

based on heuristic

inferred from title

human papilloma virus

1 reference

human papillomavirus

29 September 2024

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818672 AND SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Sherri N Sheinfeld Gorin

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818672 AND SRC:MED&resulttype=core&format=json

9 February 2020

Beth A Glenn

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818672 AND SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

1 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818672 AND SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818672 AND SRC:MED&resulttype=core&format=json

9 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818672 AND SRC:MED&resulttype=core&format=json

9 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818672 AND SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

615-639

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818672 AND SRC:MED&resulttype=core&format=json

Condom use and the risk of genital human papillomavirus infection in young women

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Prevalence of HPV infection among men: A systematic review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Human papillomavirus vaccination in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Acceptability of HPV vaccine among a national sample of gay and bisexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

HPV vaccine and males: issues and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Acceptability of human papillomavirus vaccine for males: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Seroprevalence of antibodies against human papillomavirus (HPV) types 16 and 18 in four continents: the International Agency for Research on Cancer HPV Prevalence Surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Cancer disparities by race/ethnicity and socioeconomic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Human papillomavirus vaccine among adult women: disparities in awareness and acceptance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Multicenter study of knowledge about human papilloma virus and attitudes among emergency department patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Disparities in how parents are learning about the human papillomavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Overcoming the barriers to HPV vaccination in high-risk populations in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Risk factors for rapid-onset cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Human papillomavirus: the burden of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Human papillomavirus concordance in heterosexual couples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Prevalence of HPV infection among females in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Currently approved prophylactic HPV vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Prophylactic human papillomavirus vaccines: will they do their job?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Current understanding of the mechanism of HPV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Lack of effects on fertility and developmental toxicity of a quadrivalent HPV vaccine in Sprague-Dawley rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Evaluating human papillomavirus vaccination programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Age-based programs for vaccination against HPV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Economic evaluation of human papillomavirus vaccination in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Parental Decision Making about the HPV Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Statewide HPV vaccine initiation among adolescent females in North Carolina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

The HPV vaccine: Are dosing recommendations being followed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Worsening disparities in HPV vaccine utilization among 19–26 year old women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Factors Associated With Initiation and Completion of Human Papillomavirus Vaccine Series Among Young Women Enrolled in Medicaid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Factors influencing HPV vaccination status in a Latino population; and parental attitudes towards vaccine mandates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Parental response to human papillomavirus vaccine availability: uptake and intentions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Human papillomavirus (HPV) vaccine uptake and completion at an urban hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Stage of adoption of the human papillomavirus vaccine among college women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Mother-daughter communication and human papillomavirus vaccine uptake by college students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Human papillomavirus vaccine uptake and barriers: association with perceived risk, actual risk and race/ethnicity among female students at a New York State university, 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Determinants for HPV vaccine uptake in the Netherlands: A multilevel study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Geographic disparity, area poverty, and human papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Human Papillomavirus Vaccination Practices: A Survey of US Physicians 18 Months After Licensure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Influential factors in HPV vaccination uptake among providers in four states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Gaps in vaccine financing for underinsured children in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Variation in provider vaccine purchase prices and payer reimbursement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Potential barriers to HPV vaccine provision among medical practices in an area with high rates of cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Availability of human papillomavirus vaccine at medical practices in an area with elevated rates of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Additional health care visits needed among adolescents for human papillomavirus vaccine delivery within medical homes: a national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Effect of patient reminder/recall interventions on immunization rates: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Initial lessons learned in HPV vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Multiple behavioral risk factor interventions in primary care. Summary of research evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Evaluating primary care behavioral counseling interventions: an evidence-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Cancer and disparities in health: perspectives on health statistics and research questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Hispanic women's perceptions regarding cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Examining future adolescent human papillomavirus vaccine uptake, with and without a school mandate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

The ethics and politics of compulsory HPV vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

The HPV vaccine mandate controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Cancer screening and aging: research barriers and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults11The names and affiliations of the Task Force members are listed on page v of this supplement and at http://www.thecommunityguide.org22So

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Marketing HPV vaccine: implications for adolescent health and medical professionalism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Cancer education among primary care physicians in an underserved community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Decision making in cancer primary prevention and chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Cancer screening and prevention practices of inner-city physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Using message framing to promote acceptance of the human papillomavirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Behavioral interventions to increase HPV vaccination acceptability among mothers of young girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Effects of information framing on human papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

HPV vaccine promotion: does referring to both cervical cancer and genital warts affect intended and actual vaccination behavior?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

A controlled trial of a human papillomavirus type 16 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Prospects for new human papillomavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Predictors of HPV vaccine acceptability: a theory-informed, systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Ethnic differences in human papillomavirus awareness and vaccine acceptability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Effective strategies for HPV vaccine delivery: the views of pediatricians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Improving adolescent health: focus on HPV vaccine acceptance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Influence of patient's relationship status and HPV history on physicians' decisions to recommend HPV vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

Sociodemographic factors associated with high-risk human papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12325-011-0045-X

10.1007/S12325-011-0045-X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21818672 AND SRC:MED&resulttype=core&format=json

9 February 2020

1 reference